Skip to content

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

The Effect of Ischemic Preconditioning and Physical Exercise on the Endocrine Function of Skeletal Muscle - the Effect of CoQ10 Supplementation. In Vivo and in Vitro Studies.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05412888
Enrollment
100
Registered
2022-06-09
Start date
2023-03-01
Completion date
2026-09-30
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coenzyme Q Deficiency, Exercise Training, Ischemic Preconditioning

Keywords

skeletal muscle, myokines, ischemia, inflammation

Brief summary

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.

Detailed description

Both in sport and medicine, methods are constantly sought that can significantly contribute to improving the ability of tissues to perform their functions and protecting them from effort-induced damage. In a wide range of interests, especially in people treated for ischemic changes of cardiovascular diseases, are protocols of tissue preconditioning by transient ischemia which significantly contribute to the increase in blood flow in tissue structure. Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. There is still a lack of detailed research on genetic conditions related to adaptive changes in this area of interest. In the project, the following research questions were posed: 1. What is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in IPC training, or 2 weeks of CoQ10 supplementation in the light of non-training and non-supplementation? 2. What is the relationship between two weeks of lower limb ischemia preconditioning training, or CoQ10 supplementation, and the expression of genes associated with the stress response (HSF-1, NF-kB, TNF dependent glass)? 3. What is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of preconditioning training by ischemia? 4. What is the relationship between the expression of genes associated with intracellular metabolism and the effect of CoQ10 supplementation? 5. What is the relationship between the expression of genes encoding enzymes of energy pathways (e.g. GAPDH, LDH) and IPC training or CoQ10 supplementation in the study group? 6. How does IPC training or CoQ10 supplementation affect the expression of genes responsible for membrane transport, and the Hedgehog pathway in muscle cells (including Gli1)? 7. How does IPC training affect the expression of transcription factors: Hif-1-alpha (hypoxia-induced factor) and NF-kB and selected genes dependent on their activity? HYPOTHESIS The level of gene expression associated with oxidative stress, muscle fiber development, angiogenesis, muscle cell energy, and membrane transport will change under the influence of the use of preconditioning training by deficiency or CoQ10 supplementation

Interventions

DIETARY_SUPPLEMENTCoQ10 supplementation

Young men training endurance running will be supplemented with CoQ10

PROCEDUREIschemic preconditioning training

Young men training endurance running will undergo IPC training

DIETARY_SUPPLEMENTIPC training combined with CoQ10 supplementation

Young men training endurance running will undergo IPC training combined with CoQ10 supplementation

DIETARY_SUPPLEMENTSham IPC combined with placebo

Young men training endurance running will undergo sham IPC training combined with placebo supplementation

Sponsors

Medical University of Gdansk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
21 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

- gender (males only), * not taking medication during the study, * good health (no concomitant injuries), * negative history of cardiovascular disorders, autonomic nervous system, mental disorders, cerebrospinal injuries and other diseases that may directly affect the results obtained.

Exclusion criteria

Lack of consent to participate in the research project or negative result of medical examinations.

Design outcomes

Primary

MeasureTime frameDescription
The effects of IPC on physical performance8 weeksIPC training will be combined with endurance exercise and VO2max and serum Lactate will be measured
The effects of CoQ10 supplementation on physical performance8 weeksCoQ10 supplementation combined with endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response will be measured
The effects of CoQ10 supplementation and IPC on physical performance8 weeksCoQ10 supplementation combined with IPC and endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response, ulic acid will be measured

Countries

Poland

Contacts

Primary ContactJedrzej Antosiewicz
jant@gumed.edu.pl0048 513046412
Backup ContactJedrzej Antosiewicz
jant@gumed.edu.pl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026